micronavigation EUTOS path item Registry path item Data entry

Data entry via e-CRF

The EUTOS for CML Registry provides a unique opportunity for collaboration between the ELN and Novartis, establishing a strong infrastructure for evaluating the current state of treatment for CML. The EUTOS for CML Registry is divided into three patient groups: in-study, out-study and prospective (population-based). The electronic case report form (e-CRF) is intended for the population-based section.

The EUTOS for CML Registry collects baseline, treatment and outcome data on patients with CML in Europe by implementing and enlarging the current European CML Registry and its related sub-registries in order to:

  • Provide a clear epidemiological picture of CML, and patient treatment and outcomes.
  • Promote understanding of how patients are treated in real life, outside of the trial setting, and their outcomes.
  • Develop a comprehensive prognostic model to optimize treatment.
  • Evaluate quality-controlled outcomes and implementation of ELN recommendations.
  • Create data of high scientific value.

Online access to the EUTOS – eCRF – System

Instruction sheet for EUTOS – eCRF – System
instructions, eCRF, EUTOS, registry
EUTOS registry, CRF, paper version

Technical support for the EUTOS for CML registry e-CRF

Registry Manager
Doris Lindörfer
Ludwig-Maximilians-Universität München, Germany
Tel.: +49 89 4400 7 7474
E-mail: lindoerf@ibe.med.uni-muenchen.de

Registry Technical Manager
Thomas Müller
Ludwig-Maximilians-Universität München, Germany
Tel.: + 49 89 4400 7 7484
E-mail: mueller@ibe.med.uni-muenchen.de

Help-desk available at +49 89 4400 7 7474 preferably Tuesdays and Thursdays, 14-15h, or by appointment via e-mail


Print this Document Sitemap   Contact  
European LeukemiaNet More ...